A Aralex Aachen research explorer

October 01, 2023 article Open access

Construct validity and responsiveness of feasible composite disease activity measures for use in daily clinical practice in patients with psoriatic arthritis

DOI: 10.1136/rmdopen-2022-002972 Full text (OA) OpenAlex

Authors 0

Author list not loaded yet.

Cited by 0 stored of 7

References 2

Efficacy and safety of guselkumab in patients with active psoriatic arthritis who are inadequate responders to tumour necrosis factor inhibitors: results through one year of a phase IIIb, randomised, controlled study (COSMOS)
2021 Annals of the Rheumatic Diseases article Medicine Spondyloarthritis Studies and Treatments Open access cited by 2 patents

104

citations
POS1043 STRONG CORRELATION BETWEEN SHORT- VS LONG-FORM COMPOSITE MEASURES OF PSORIATIC ARTHRITIS DISEASE ACTIVITY IN A TNFi-IR POPULATION TREATED WITH GUSELKUMAB: DATA FROM THE PHASE 3b COSMOS TRIAL
2022 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments Open access

2

citations

2 results